Toolkits are practical guides for anyone working on issues relating to MeTA. They can also be used more generally as a guideline for anyone working on transparency alliances. Each toolkit covers a particular area of work and comprises a number of ‘How to…’ guides. These guides are designed to be used both as part of the whole toolkit or as individual items.

MeTA Baseline Assessment Toolkits

The MeTA pilot countries were encouraged and supported to assess their "baseline" pharmaceutical situation.

A set of tools and technical assistance were developed to assist country multi-stakeholder groups in getting pharmaceutical sector data, cataloguing key areas of data disclosure and pulling together information to help with prioritising areas of work and producing baseline country reports.

This baseline assessment enabled country-specific indicators to be identified by the MeTA multi-stakeholder groups. These indicators are used to track progress and demonstrate the levels of engagement of different stakeholders. However, just as importantly, they will provide the foundation for longer term evaluation of outcomes and impact beyond any pilot phase.

The baseline assessment will vary depending on the local situation. There are three key components to the assessment.  Implementing Component 1 is a necessary and core part of any pharmaceutical transparency initiative, although applying all the components in your country will depend on local resources:

 

• Component 1: An inventory of existing pharmaceutical sector data that is then made publicly available
  • Component 1A: Pharmaceutical Sector Scan
    Instructions; Data Collection Tables; Supporting Sources and Comments; 
  • Component 1B: Data Disclosure Survey
    Data Disclosure Survey Tool.

• Component 2: An indication of the degree of community access to essential medicines, through healthcare facility and household surveys.
  • WHO Level II Health Facility Survey; WHO level II Household Survey manual;
  • Supporting documents and further information on WHO tools for assessing pharmaceutical situation in countries.

• Component 3: A guide to assessing the quality of the multi-stakeholder process:
  
  • Assessing Multi-Stakeholder Processes (Guidance document which contains the majority of the tools needed - please download the other tools separately below):
  
  
  • Tool 1 - Introduction to Multistakeholder Assessment SO
  • Tool 7 - Stakeholder Interview Matrix
  • Tool 9 - Design Workshop Slideset
  • Tool 13 - Stakeholder Workshop Slideset
  • Tool 14 - Stakeholder Workshop Facilitation Plan SO

The International MeTA Secretariat and the WHO have worked with the WHO Collaborating Centre in Pharmaceutical Policy at Harvard University and the Institute of Development Studies to develop these tools.

Routine Country Reporting Template

The country reporting template intends to provide a simple snapshot of quarterly progress of the multi-stakeholder process in countries in terms of:

• progress against workplan
• outputs and indicators
• challenges
• emerging priorities